The issue opened for bidding on Thursday (4 July 2024) and it will close on Monday (08 July 2024). The price band of the IPO is fixed between Rs 65 to Rs 68 per share. The minimum order quantity is 2,000 equity shares. The equity shares will list on NSE’s SME platform.

The issue size comprises of fresh issue of 62,58,000 and offer for sale (OFS) of 3,12,000 shares by existing promoter.

The promoter and promoter group shareholding will dilute to 69.90% from 94.97% pre-offer.

About 3,30,000 equity shares will be reserved for subscription by market maker to the issue. The net issue comprises of 62,40,000 equity shares. The issue and the net issue will constitute 26.34 % and 25.01% respectively of the post offer paid up equity share capital of the company.

The company intends to utilize the net proceeds to meet working capital requirement, issue related expenses and general corporate purpose.

Ahead of the IPO, Ambey Laboratories on Wednesday, 03 July 2024, raised Rs 12.70 crore from anchor investors. The board allotted 18.68 lakh shares at Rs 68 per share to 5 anchor investors.

Ambey Lab is engaged in the business of manufacturing of agrochemical products for the protecting of crops. It carries on the activities in the field of manufacturing chemicals, compounds, herbal products, insecticides, pesticides and fungicides. Its operations spread across India and abroad with manufacturing facility in Rajasthan- India. The company works within an interconnected network alongside Aromatic Rasayan Private and OFB Tech Private. As on 31 January 2024, the company has 195 full time employees

The company recorded revenue from operations of Rs 100.31 crore and net profit of Rs 6.02 crore for the period as on 31 January 2024.